Clinical Trial
doi: 10.1016/s0015-0282(00)00471-4.
A comparative study of high fixed-dose and decremental-dose regimens of gonadotropins in a minidose gonadotropin-releasing hormone agonist flare protocol for poor responders
- PMID: 10785239
- DOI: 10.1016/s0015-0282(00)00471-4
Item in Clipboard
Clinical Trial
A comparative study of high fixed-dose and decremental-dose regimens of gonadotropins in a minidose gonadotropin-releasing hormone agonist flare protocol for poor responders
Fertil Steril.
2000 May.
Free article
No abstract available
Similar articles
-
Higher leuprolide dose does not diminish the ovarian response to gonadotropins in a protocol using pre-treatment with oral contraceptives.Int J Gynaecol Obstet. 2010 Jan;108(1):69-70. doi: 10.1016/j.ijgo.2009.08.026. Int J Gynaecol Obstet. 2010. PMID: 19892344 No abstract available.
-
Cessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor responders.J Assist Reprod Genet. 2002 Jan;19(1):1-6. doi: 10.1023/a:1014026220880. J Assist Reprod Genet. 2002. PMID: 11893009 Free PMC article.
-
A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.Fertil Steril. 2010 Feb;93(2):360-3. doi: 10.1016/j.fertnstert.2008.11.007. Epub 2009 Jan 7. Fertil Steril. 2010. PMID: 19131055
-
A rational approach to the management of low responders in in-vitro fertilization.Hum Reprod. 1999 Jul;14(7):1744-8. doi: 10.1093/humrep/14.7.1744. Hum Reprod. 1999. PMID: 10402380 Review. No abstract available.
-
Agonist or antagonist: what is preferable for in vitro fertilization?Gynecol Endocrinol. 2012 Mar;28 Suppl 1:18-21. doi: 10.3109/09513590.2012.651928. Gynecol Endocrinol. 2012. PMID: 22394299 Review. No abstract available.
Cited by
-
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).Reprod Biol Endocrinol. 2021 May 11;19(1):68. doi: 10.1186/s12958-021-00744-x. Reprod Biol Endocrinol. 2021. PMID: 33975610 Free PMC article.
-
ESHRE guideline: ovarian stimulation for IVF/ICSI†.Hum Reprod Open. 2020 May 1;2020(2):hoaa009. doi: 10.1093/hropen/hoaa009. eCollection 2020. Hum Reprod Open. 2020. PMID: 32395637 Free PMC article.
-
Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why.Front Endocrinol (Lausanne). 2018 Aug 17;9:461. doi: 10.3389/fendo.2018.00461. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30174650 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
